Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Metabolomics: moving to the clinic.
Nordström A, Lewensohn R. Nordström A, et al. Among authors: lewensohn r. J Neuroimmune Pharmacol. 2010 Mar;5(1):4-17. doi: 10.1007/s11481-009-9156-4. Epub 2009 Apr 28. J Neuroimmune Pharmacol. 2010. PMID: 19399626 Review.
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Baumann P, et al. Among authors: lewensohn r. J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414667 Clinical Trial.
miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.
Salim H, Arvanitis A, de Petris L, Kanter L, Hååg P, Zovko A, Özata DM, Lui WO, Lundholm L, Zhivotovsky B, Lewensohn R, Viktorsson K. Salim H, et al. Among authors: lewensohn r. Genes Chromosomes Cancer. 2013 Oct;52(10):895-911. doi: 10.1002/gcc.22085. Epub 2013 Aug 9. Genes Chromosomes Cancer. 2013. PMID: 23929716
Affinity prefractionation for MS-based plasma proteomics.
Pernemalm M, Lewensohn R, Lehtiö J. Pernemalm M, et al. Among authors: lewensohn r. Proteomics. 2009 Mar;9(6):1420-7. doi: 10.1002/pmic.200800377. Proteomics. 2009. PMID: 19235168 Review.
Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery.
Pernemalm M, Orre LM, Lengqvist J, Wikström P, Lewensohn R, Lehtiö J. Pernemalm M, et al. Among authors: lewensohn r. J Proteome Res. 2008 Jul;7(7):2712-22. doi: 10.1021/pr700821k. Epub 2008 Jun 13. J Proteome Res. 2008. PMID: 18549256
Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J, Pernemalm M, Tan CS, Lindberg M, Kanter L, Pawitan Y, Lewensohn R, Stenke L, Lehtiö J. Forshed J, et al. Among authors: lewensohn r. J Proteome Res. 2008 Jun;7(6):2332-41. doi: 10.1021/pr070482e. Epub 2008 May 2. J Proteome Res. 2008. PMID: 18452325
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.
Linderholm BK, Hellborg H, Johansson U, Elmberger G, Skoog L, Lehtiö J, Lewensohn R. Linderholm BK, et al. Among authors: lewensohn r. Ann Oncol. 2009 Oct;20(10):1639-46. doi: 10.1093/annonc/mdp062. Epub 2009 Jun 23. Ann Oncol. 2009. PMID: 19549711
Current status of prognostic immunohistochemical markers for urothelial bladder cancer.
Rosenblatt R, Jonmarker S, Lewensohn R, Egevad L, Sherif A, Kälkner KM, Nilsson S, Valdman A, Ullén A. Rosenblatt R, et al. Among authors: lewensohn r. Tumour Biol. 2008;29(5):311-22. doi: 10.1159/000170878. Epub 2008 Nov 5. Tumour Biol. 2008. PMID: 18984977 Review.
Systems biology approaches to develop innovative strategies for lung cancer therapy.
Viktorsson K, Lewensohn R, Zhivotovsky B. Viktorsson K, et al. Among authors: lewensohn r. Cell Death Dis. 2014 May 29;5(5):e1260. doi: 10.1038/cddis.2014.28. Cell Death Dis. 2014. PMID: 24874732 Free PMC article. Review.
Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion.
Pernemalm M, De Petris L, Eriksson H, Brandén E, Koyi H, Kanter L, Lewensohn R, Lehtiö J. Pernemalm M, et al. Among authors: lewensohn r. Proteomics. 2009 Jul;9(13):3414-24. doi: 10.1002/pmic.200800814. Proteomics. 2009. PMID: 19609957
194 results
Jump to page